|
Active substance |
Lacosamide |
|
Holder |
Clinigen group |
|
Status |
Closed |
|
Indication |
Partial-onset or generalized tonic clonic seizures in patients ≥ 16 years of age coming from the SP0994 clinical trial |
|
Public documents |
|
|
Last update |
15/05/2019 |
Vimpat®
Last updated on 10/09/2024